These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 24511669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation.
    Na GH, Kim DG, Han JH, Kim EY, Lee SH, Hong TH, You YK, Choi JY.
    J Gastroenterol Hepatol; 2014 Jan; 29(1):151-6. PubMed ID: 24117684
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.
    Viganò M, Bhoori S, Lampertico P, Donato MF, Iavarone M, Grossi G, Facciorusso A, Caccamo L, Rossi G, Colombo M, Mazzaferro V.
    Liver Int; 2015 Sep; 35(9):2187-93. PubMed ID: 25809541
    [Abstract] [Full Text] [Related]

  • 6. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC, Kim SH, Lee SD, Park H, Lee SA, Park SJ.
    World J Gastroenterol; 2016 Apr 14; 22(14):3803-12. PubMed ID: 27076765
    [Abstract] [Full Text] [Related]

  • 7. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
    Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS.
    J Gastroenterol Hepatol; 2011 Nov 14; 26(11):1638-45. PubMed ID: 22011297
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B and hepatocellular carcinoma recurrence after living donor liver transplantation: The role of the Milan criteria.
    Vatansever S, Farajov R, Yılmaz HC, Zeytunlu M, Paköz ZB, Kılıç M.
    Turk J Gastroenterol; 2019 Jan 14; 30(1):75-80. PubMed ID: 30644364
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
    Lao XM, Luo G, Ye LT, Luo C, Shi M, Wang D, Guo R, Chen M, Li S, Lin X, Yuan Y.
    Liver Int; 2013 Apr 14; 33(4):595-604. PubMed ID: 23402625
    [Abstract] [Full Text] [Related]

  • 12. Antiviral treatment for hepatitis B virus recurrence following liver transplantation.
    Lee S, Kwon CH, Moon HH, Kim TS, Roh Y, Song S, Shin M, Kim JM, Park JB, Kim SJ, Joh JW, Lee SK.
    Clin Transplant; 2013 Apr 14; 27(5):E597-604. PubMed ID: 24093615
    [Abstract] [Full Text] [Related]

  • 13. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Chang MS, Olsen SK, Pichardo EM, Stiles JB, Rosenthal-Cogan L, Brubaker WD, Guarrera JV, Emond JC, Brown RS.
    Transplantation; 2013 Apr 15; 95(7):960-5. PubMed ID: 23545507
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A, Ghisetti V, Marzano A, Romagnoli R, Salizzoni M.
    Liver Transpl; 2005 Aug 15; 11(8):922-8. PubMed ID: 16035057
    [Abstract] [Full Text] [Related]

  • 16. Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.
    Campsen J, Zimmerman M, Trotter J, Hong J, Freise C, Brown R, Cameron A, Ghobrial M, Kam I, Busuttil R, Saab S, Holt C, Emond J, Stiles J, Lukose T, Chang M, Klintmalm G.
    Liver Transpl; 2013 Sep 15; 19(9):1020-9. PubMed ID: 23852663
    [Abstract] [Full Text] [Related]

  • 17. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
    Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, Sharr W, Dai WC, Chan AC, Cheung TT, Tsang S, Lam B, Lai CL, Lo CM.
    Gastroenterology; 2011 Oct 15; 141(4):1212-9. PubMed ID: 21762659
    [Abstract] [Full Text] [Related]

  • 18. Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy.
    Hwang S, Lee SG, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Park JI, Ryu JH, Lee HJ, Suh DJ, Lim YS.
    Liver Transpl; 2008 Jun 15; 14(6):770-8. PubMed ID: 18508369
    [Abstract] [Full Text] [Related]

  • 19. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P.
    Hepatology; 1995 Jun 15; 21(6):1492-9. PubMed ID: 7768492
    [Abstract] [Full Text] [Related]

  • 20. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E, Strasser SI, Koorey DJ, Verran D, McCaughan GW.
    Clin Transplant; 2006 Jun 15; 20(3):369-73. PubMed ID: 16824156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.